Andrographolide radiosensitizes human ovarian cancer SKOV3 xenografts due to an enhanced apoptosis and autophagy

Tumor Biology

Volumn 36, Issue 11, 2015, Pages 8359-8365

  Zhang, Chao ^a,b   Qiu, Xingsheng ^c  

^a Panyu Central Hospital   (China)

^b Cancer Institute of Panyu   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Andrographolide; Apoptosis; Autophagy; Ovarian cancer; Radiation

Indexed keywords

ANDROGRAPHOLIDE; AUTOPHAGY PROTEIN 5; BECLIN 1; CASPASE 3; DANSYLCADAVERINE; MEMBRANE PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN LC3 I; PROTEIN LC3 II; PROTEIN P53; UNCLASSIFIED DRUG; DITERPENE; RADIOSENSITIZING AGENT; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER GROWTH; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; OVARY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIZATION; TUMOR XENOGRAFT; TUNEL ASSAY; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION REGULATION; OVARIAN NEOPLASMS; PATHOLOGY; RADIATION TOLERANCE; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL PROLIFERATION; DITERPENES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84949091626     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3578-9     Document Type: Article

References (29)

1. Malvezzi M, Arfe A, Bertuccio P, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2011. Ann Oncol. 2011;22:947–56.
2. Agarwal R, Kaye SB. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer. 2003;3:502–16.
3. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248–59.
4. Poolsup N, Suthisisang C, Prathanturarug S, Asawamekin A, Chanchareon U. Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials. J Clin Pharm Ther. 2004;29:37–45.
5. Puri A, Saxena R, Saxena RP, Saxena KC. Immunostimulant agents from Andrographis paniculata. J Nat Prod. 1993;56:995–9.
6. Singh RP, Banerjee S, Rao AR. Modulatory influence of Andrographis paniculata on mouse hepatic and extrahepatic carcinogen metabolizing enzymes and antioxidant status. Phytother Res. 2001;15:382–90.
7. Kumar RA, Sridevi K, Kumar NV, Nanduri S, Rajagopal S. Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol. 2004;92:291–5.
8. Iruretagoyena MI, Tobar JA, González PA, Sepúlveda SE, Figueroa CA, Burgos RA, et al. AND interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse. J Pharmacol Exp Ther. 2005;312:366–72.
9. Shi MD, Lin HH, Lee YC, Chao JK, Lin RA, Chen JH. Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by AND. Chem Biol Interact. 2008;174:201–10.
10. Tan Y, Chiow KH, Huang D, Wong SH. AND regulates epidermal growth factor receptor and transferrin receptor trafficking in epidermoid carcinoma (A-431) cells. Br J Pharmacol. 2010;159:1497–510.
11. Sheeja K, Guruvayoorappan C, Kuttan G. Antiangiogenic activity of Andrographis paniculata extract and AND. Int Immunopharmacol. 2007;7:211–21.
12. Cheung HY, Cheung SH, Li J, Cheung CS, Lai WP, Fong WF, et al. AND isolated from Andrographis paniculata induces cell cycle arrest and mitochondrial-mediated apoptosis in human leukemic HL-60 cells. Planta Med. 2005;71:1106–11.
13. Shi MD, Lin HH, Chiang TA, Tsai LY, Tsai SM, Lee YC, et al. AND could inhibit human colorectal carcinoma Lovo cells migration and invasion via down-regulation of MMP-7 expression. Chem Biol Interact. 2009;180:344–52.
14. Lin HH, Shi MD, Tseng HC, Chen JH. AND sensitizes the cytotoxicity of human colorectal carcinoma cells toward cisplatin via enhancing apoptosis pathways in vitro and in vivo. Topical Sci. 2014;139:108–20.
15. Gerl R, Vaux DL. Apoptosis in the development and treatment of cancer. Carcinogenesis. 2005;26:263–70.
16. Cerrito MG, Scaqliarini A, Froio A, Liloia A, Busnelli M, Giovannoni, et al. Heme oxygenase-1 inhibition prevents intimal hyperplasia enhancing nitric oxide-dependent apoptosis of vascular smooth muscle cell. Biol Pharm Bull. 2011;34:1204–14.
17. Yoshimori T. Autophagy: paying Charon’s toll. Cell. 2007;128:833–6.
18. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290:1717–21.
19. Wang ZM, Kang YH, Yang X, Wang JF, Zhang Q, Yang BX, et al. Andrographolide radiosensitizes human esophageal cancer cell line ECA109 to radiation in vitro. Dis Esophagus. 2014. doi:10.1111/dote.12255.
20. Torchinsky A, Shepshelovich J, Orenstein H, Zaslavsky Z, Savion S, Carp H, et al. TNF-alpha protects embryos exposed to developmental toxicants. Am J Reprod Immunol. 2003;49:159–68.
21. Wang J, Whiteman MW, Lian H, Wang G, Singh A, Huang D, et al. A non-canonical MEK/ERK signaling pathway regulates autophagy via regulating Beclin 1. J Biol Chem. 2009;284:21412–24.
22. Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75:311–35.
23. Tsai HR, Yang LM, Tsai WJ, Chiou WF. Andrographolide acts through inhibition of ERK1/2 and Akt phosphorylation to suppress chemotactic migration. Eur J Pharmacol. 2004;498:45–52.
24. Zhou J, Zhang S, Ong CN, Shen HM. Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells. Biochem Pharmacol. 2006;72:132–44.
25. Hung SK, Hung LC, Kuo CD, Lee KY, Lee MS, Lin HY, et al. Andrographolide sensitizes Ras-transformed cells to radiation in vitro and in vivo. Int J Radiat Oncol Biol Phys. 2010;77:1232–9.
26. Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005;5:726–34.
27. Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol. 2007;8:275–83.
28. Cheng Y, Qiu F, Tashiro S, Onodera S, Ikejima T. ERK and JNK mediate TNFalpha-induced p53 activation in apoptotic and autophagic L929 cell death. Biochem Biophys Res Commun. 2008;376:483–8.
29. Cheng Y, Qiu F, Huang J, Tashiro S, Onodera S, Ikejima T. Apoptosis-suppressing and autophagy-promoting effects of calpain on oridonin-induced L929 cell death. Arch Biochem Biophys. 2008;475:148–55.